[HTML][HTML] Nanotechnology as a promising approach to combat multidrug resistant bacteria: a comprehensive review and future perspectives

HF Hetta, YN Ramadan, AI Al-Harbi, E A. Ahmed… - Biomedicines, 2023 - mdpi.com
The wide spread of antibiotic resistance has been alarming in recent years and poses a
serious global hazard to public health as it leads to millions of deaths all over the world. The …

[HTML][HTML] Inhalation delivery for the treatment and prevention of COVID-19 infection

BB Eedara, W Alabsi, D Encinas-Basurto, R Polt… - Pharmaceutics, 2021 - mdpi.com
Coronavirus disease-2019 (COVID-19) is caused by coronavirus-2 (SARS-CoV-2) and has
produced a global pandemic. As of 22 June 2021, 178 million people have been affected …

[HTML][HTML] Approved and marketed nanoparticles for disease targeting and applications in COVID-19

AAH Abdellatif, AF Alsowinea - Nanotechnology Reviews, 2021 - degruyter.com
Nano-based systems can be used to transport active medicinal products to specific parts of
the body. Most challenges with drug delivery, such as low water solubility and poor …

Liposome-Based Antibacterial Delivery: An Emergent Approach to Combat Bacterial Infections

R Ghosh, M De - ACS omega, 2023 - ACS Publications
The continued emergence and spread of drug-resistant pathogens and the decline in the
approval of new antimicrobial drugs pose a major threat to managing infectious diseases …

Could nanotechnology help to end the fight against COVID-19? Review of current findings, challenges and future perspectives

AT Yayehrad, EA Siraj, GB Wondie… - International Journal …, 2021 - Taylor & Francis
A serious viral infectious disease was introduced to the globe by the end of 2019 that was
seen primarily from China, but spread worldwide in a few months to be a pandemic. Since …

[HTML][HTML] Current trends and prospects for application of green synthesized metal nanoparticles in cancer and COVID-19 therapies

LS Mbatha, J Akinyelu, CI Chukwuma, MP Mokoena… - Viruses, 2023 - mdpi.com
Cancer and COVID-19 have been deemed as world health concerns due to the millions of
lives that they have claimed over the years. Extensive efforts have been made to develop …

[HTML][HTML] Nanoparticles in clinical trials of COVID-19: An update

A Rauf, T Abu-Izneid, AA Khalil, N Hafeez… - International Journal of …, 2022 - Elsevier
Abstract Once the World Health Organization (WHO) declared the COVID-19 (Coronavirus
Infectious Disease-19) outbreak to be pandemic, massive efforts have been launched by …

[HTML][HTML] Aerosol pulmonary immune engineering

ER Sudduth, M Trautmann-Rodriguez, N Gill… - Advanced Drug Delivery …, 2023 - Elsevier
Aerosolization of immunotherapies poses incredible potential for manipulating the local
mucosal-specific microenvironment, engaging specialized pulmonary cellular defenders …

[HTML][HTML] Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19

S Alipour, L Mahmoudi, F Ahmadi - Drug delivery and translational …, 2023 - Springer
The recent outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China has spread
rapidly around the world, leading to a widespread and urgent effort to develop and use …

[HTML][HTML] Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary sequelae after COVID-19 Infection

V Ruggiero, RP Aquino, P Del Gaudio, P Campiglia… - Pharmaceutics, 2022 - mdpi.com
Post-COVID syndrome or long COVID is defined as the persistence of symptoms after
confirmed SARS-CoV-2 infection, the pathogen responsible for coronavirus disease. The …